DIMENSIONAL FUND ADVISORS LP

Position in PRLD — Prelude Therapeutics Inc

CIK 354204 AUSTIN, TX

Position in PRLD

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$187,668

+$67,251 QoQ

Shares Held

35,210

0.0% QoQ

Ownership

0.044%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#33

of 75 holders

Holding Since

Sep 2022

12 quarters on record

Voting authority Sole 94% Shared 6% None 0%

Healthcare · as of Jun 30, 2026

DIMENSIONAL FUND ADVISORS LP holds $6,163,799,259 across 230 Biotechnology names. PRLD ranks #191 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	1,168,956	$580,655,511
2	JAZZ	Jazz Pharmaceuticals plc	1,713,592	$412,924,262
3	REGN	Regeneron Pharmaceuticals, Inc.	559,687	$348,987,230
4	INCY	Incyte Corp	2,280,803	$258,551,825
5	EXEL	Exelixis, Inc.	4,426,620	$240,852,392
6	BMRN	Biomarin Pharmaceutical Inc	4,075,714	$233,212,353
7	ROIV	Roivant Sciences Ltd.	5,230,417	$185,104,455
8	KRYS	Krystal Biotech, Inc.	476,038	$176,929,041

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$187,668	35,210	0.0%	Shares	Sole	2026-08-11
2026-03-31	$120,417	35,210	+220.6%	Shares	Sole	2026-05-07
2024-12-31	$13,998	10,981	-62.2%	Shares	Sole	2025-02-13
2024-09-30	$60,198	29,082	+0.0%	Shares	Sole	2024-11-07
2024-06-30	$110,770	29,074	+103.2%	Shares	Sole	2024-08-09
2024-03-31	$67,805	14,305	0.0%	Shares	Sole	2024-05-10
2023-12-31	$61,080	14,305	+27.9%	Shares	Sole	2024-02-07
2023-09-30	$34,569	11,188	-20.8%	Shares	Sole	2023-11-09
2023-06-30	$63,589	14,131	+10.8%	Shares	Sole	2023-08-09
2023-03-31	$72,725	12,759	0.0%	Shares	Sole	2023-05-12
2022-12-31	$77,063	12,759	-12.7%	Shares	Sole	2023-02-09
2022-09-30	$96,611	14,616	—	Shares	Sole	2022-11-10
No filing history on record for this holder in this stock.